FDA clears Pfizer and Moderna's bivalent boosters, seeking to slow the next wave of Omicron
As part of an attempt to halt a likely new surge of hospitalizations and deaths from Omicron’s BA.5 subvariant this fall, the FDA on Wednesday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
